Carlos Santos

Founder and Chief Executive Officer

Carlos Santos is a qualified expert, who works in Affigen main office of which is in 100. as a Founder and Chief Executive Officer since 2016. Carlos Santos has earned professional experience in more than seven positions at various companies. Carlos Santos went to the University of Michigan - Rackham Graduate School and got education there from 2001 to 2008. Austin, Texas is the area, where this expert was lastly known to live. This expert's email address and phone can be accessed through SoftwareOfficial on demand.
Name variants:
Carlos Santos
Last updated Jul 05, 2024

Contact Information

Last Update
Jul 8, 2022
Email
cs**@umich.edu
Location
Austin, TX
Company
Affigen

Workplace

Founder and Chief Executive Officer

Work History

Founder and Chief Executive Officer

Saint Louis, MO
Affigen develops tumor-identifying therapies to treat cancer, delivering unprecedented specificity, safety & efficacy. We were founded in 2016 by immuno-oncology and mass-personalized cGMP p...
Jan 2016 — Nov 2019

Founder and Chief Executive Officer

from Nov 2019

Founder and Chief Executive Officer

from Mar 2018

Founder and Chief Executive Officer

20 south Sarah St, Saint Louis, MO 63108
We develop therapeutics to address the severe unmet medical needs posed by tropical diseases. In collaboration with our partners in global health, our initial drug development program focuse...
from Jan 2016

Managing Partner

Saint Louis, MO
We're a multi-disciplinary team of entrepreneurs – physicians, scientists, engineers, financiers – dedicated to launching and building transformative life sciences companies. We combine deep...
from Jan 2016

Chief Executive Officer

8500 Evergreen Blvd northwest, Minneapolis, MN 55433
We develop active cancer vaccines (active personalized immunotherapy) targeting life-threatening immune cancers. As part of our mission to develop truly autologous personalized vaccines, we ...
Jul 2013 — May 2015

Chief Science Officer

Immunotherapy development for oncology and autoimmune disease. I led the development of the BiovaxID therapeutic vaccine for Non-Hodgkin's Lymphoma and Cyrevia for autoimmune disease.
Jan 2003 — Jun 2013

Occupations

Executive
Chief Executive Officer
Founder
Scientist
Biotechnology Professional
Corporate Executive
Chief Executive
Founding Member
Biologist
Biological Scientist

Skills

Biotechnology
Vaccines
Cancer
Oncology
Science
Life Sciences
Genomics
Clinical Development
Pharmaceutical Industry
Molecular Biology
R&D
Clinical Trials
Immunotherapy
Cell Culture
Biostatistics
Hardware Diagnostics
Lifesciences
Drug Discovery
Biochemistry
Strategic Planning
Active Immunotherapy
Cancer Vaccines
Drug Development
Gmp
Biopharmaceuticals
Cell Biology
Immunology
Biomarkers
Login